[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_1035 

# __Enhanced innovation and technological capacity__

## Articles mentionning this Benefit

* [COVID-19 risks and systemic gaps in Nigeria: resilience building lessons for pandemic and climate change management](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_215.md)

## Category to which it belongs

* [Expanded vaccination capabilities lead to improved healthcare capacity, equitable distribution, and enhanced response and technological capabilities.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_31.md)

## Description of actual returns pertaining to this benefit

* [Private investors in research and development can benefit from increased demand for innovative solutions and technologies, as well as potential intellectual property rights and commercialization opportunities.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_1160.md)

## Name of the Benefit

Increased investment in research and development boosts innovation and technological capacity, enabling the development of new solutions, products, and services to address current and future challenges.

## Risks which can benefit from this action

* [Invest in research and development](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1041.md)

## Stakeholders benefitting from this Benefit

* [Government](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_73.md)
* [Industries](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_389.md)

